Your search returned 2 results.

Sort
Unhighlight Highlight
Select all Clear all
Select titles to:
Results
1.
Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naive chronic lymphocytic leukemia: a phase 2 study. MedStar authors:
  • Desai, Sanjal
PMID:
  • 33653216
Year: 2021
Citation:
  • Leukemia & Lymphoma. 62(8):1816-1827, 2021 08.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahn IE, Desai S, Drinkwater DC, Farooqui MZ, Gaglione EM, Herman SEM, Hughes TE, Lindorfer MA, Lotter J, Maric I, Marti GE, Mo C, Nichols C, Nierman P, Pleyer C, Soto S, Stetler-Stevenson M, Sun C, Superata J, Taylor RP, Tian X, Valdez J, Wake L, Wiestner A, Yuan CM
DOI:
Add to cart
2.
A patient with melanoma that became sensitized to immunotherapy after treatment with a CDK4/6 inhibitor. MedStar authors:
  • Alzeer, Ali Hazem
  • Zaemes, Jacob
PMID:
  • 32640856
Year: 2020
Citation:
  • Immunotherapy. 12(12):861-867, 2020 08.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Internal Medicine Residency
  • Pathology Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Alzeer A, Atkins M, Villa K, Zaemes J
DOI:
Add to cart
Pages

Powered by Koha